Last Updated February 9, 2024

 February 9, 2024

Concerned about ipamorelin side effects?

Many peptide researchers are interested in conducting ipamorelin studies. It has the proven ability to increase GH levels and influence overall body composition and levels of body fat in test subjects.

But is it safe to research?

Based on the available research, ipamorelin treatment appears to create few adverse effects in test subjects. 

This guide will offer all the necessary information that researchers may need to decide whether ipamorelin could be the right research peptide for future study. A full overview of the side effects that may be expected when ipamorelin is administered to research subjects will be presented.

Buy Ipamorelin from the top-rated research peptides vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.


What is Ipamorelin?

Ipamorelin is a pentapeptide (a peptide containing five amino acids) that mimics ghrelin, a naturally occurring hormone produced by enteroendocrine cells in the gastrointestinal tract [1]. Ghrelin is responsible for several anabolic processes in the body including [2]:

  • Energy usage
  • Appetite suppression
  • Fat processing

As a ghrelin mimetic, ipamorelin significantly influences the GI system, body composition, and adiposity. It is also classified as a growth hormone (GH) secretagogue due to its ability to increase the secretion of GH and insulin growth-factor 1 (IGF-1) in the body.

What makes ipamorelin unique is that it is the world’s first selective GH secretagogue. This means that it binds to the same receptors as does endogenous ghrelin (the GHSR-1a receptors) and that it stimulates the cells in the pituitary gland to release more GH without raising ACTH or cortisol levels [3].

Ipamorelin’s secondary effect is that it reduces the amount of somatostatin, a GH-inhibiting hormone. By reducing somatostatin, ipamorelin is able to raise levels of endogenous GH and IGF-1 on par with what is possible with exogenous GH therapy [3].


ipamorelin side effects


Benefits of Ipamorelin

Ipamorelin is a research peptide that lacks U.S. Food and Drug Administration approval and has no recognized medical uses. However, here is a brief review of the benefits of ipamorelin as observed during various studies.

  • Improved gastric motility: Two studies have linked ipamorelin to improved gastric motility [4, 5]. Greenwood-Van Meerveld et al. found that ipamorelin accelerated gastric emptying in adult male rats [4]. Beck et al. found that ipamorelin did not improve measured outcomes (time to first tolerated meal and first bowel movement) any better than a placebo, but data from this study showed that ipamorelin treatment may help open laparotomy patients recover faster [5, 6, 7].
  • Increased GH-release: K Raun et al. found that ipamorelin can stimulate GH release in animals (swine and rats) to an extent comparable with GHRP-6 [3]. Other research has shown that ipamorelin can increase GH and body weight in rats [8].
  • Increased body weight: Various animal studies have linked ipamorelin to body weight gain [8, 9]. Lall et al. found that GH-deficient and non-GH-deficient mice that received twice-daily injections of ipamorelin increased their body weight by 15.3% and 16.9% respectively in just 9 weeks. Dissections revealed that ipamorelin did not increase the weight or size of the rodents’ internal organs [9].
  • Potential treatment for male hypogonadism: Deepankar et al. indicated that ipamorelin may help with weight gain in hypogonadal males [6].
  • Purported anabolic benefits: Due to ipamorelin’s ability to increase GH secretion and body weight gain in animals [9], there is a good deal of speculation as to whether this peptide can be administered for muscle growth and fat loss. While GH therapy (not ipamorelin) has been shown to increase lean body mass and decrease fat mass in recreational athletes [10], there is no evidence showing that ipamorelin offers these benefits. Based on animal studies, ipamorelin actually increases the total body fat percentage of non-GH-deficient rodents [9].
  • Purported anti-aging benefits: Anecdotal evidence shows that many anti-aging clinics tout ipamorelin as an anti-aging treatment that can reduce visible signs of aging. While there is evidence that growth hormone (GH) secretagogues like ipamorelin can increase lean body mass and decrease fat mass in seniors [11], long-term research shows that elevated GH levels increase disease risks and decrease life expectancy by accelerating the aging process [12].

Ipamorelin Side Effects | A Comprehensive Overview

Ipamorelin appears to have a significant influence on the GI system, adiposity, and overall body composition when administered to test subjects. However, it also produces some direct and indirect side effects. Here’s what researchers must know.

First, it's important to note that data from human clinical trials involving ipamorelin is extremely limited. To date, ipamorelin’s efficacy has only been tested in one phase 2 clinical trial, which was a small, proof of concept study that involved just 114 participants [5]. While safety data from this trial is encouraging, the sample size is too small for any meaningful conclusions to be drawn.

Second, while animal studies have found that ipamorelin increases GH secretion and body weight gain in rodents without increasing liver size, as GH can, these studies were of short duration [9]. The long-term use of ipamorelin for increasing GH secretion has yet to be studied and findings are, at best, preliminary [11].

Below, we will examine the most common side effects associated with ipamorelin.

Mild ipamorelin side effects

According to Deepankar et al. adverse effects associated with ipamorelin treatment are rare and similar to those reported with sermorelin [6]. These include:

  • Redness, itching, pain, rashes, and sensitivity at the site of injection
  • Dry mouth
  • Nausea
  • Headaches
  • Lightheadedness
  • Fever (that is transient, and goes away quickly)

Some of these side effects are easily avoided or treated. For example, changing the site of injections should help reduce pain or irritation at that particular spot.

Other possible ipamorelin side effects

There is currently no data from clinical trials linking ipamorelin to major side effects in humans. However, this is more to do with how little the peptide has been researched. To date, the only human trial involving ipamorelin was just 7 days long [5], which is clearly insufficient to draw any conclusions about this peptide's long-term side effects.

While the long-term safety of ipamorelin has yet to be evaluated, we can surmise that, as a growth hormone (GH) secretagogue, long-term ipamorelin therapy may indirectly produce side effects associated with elevated GH levels. As noted by Barkte, supranormal GH levels have been associated with [12]:

  • Increased disease risks
  • Reduced life expectancy
  • Acceleration of aging

However, Deepankar et al. found that ipamorelin did not raise serum levels of GH and IGF-1 beyond “physiological norms” [6]. This suggests that it may not carry the same risks associated with exogenous GH therapy, which include joint stiffness, radiculopathy, and the risk of edema.

While ipamorelin could offer therapeutic and clinical potential, its long-term side effects have yet to be studied and this remains a clear area for further research.


ipamorelin side effects


Where to Buy Ipamorelin Online? | 2024 Edition

The sale of research peptides is loosely regulated across the English-speaking world, and many companies sell substandard imported products. Researchers interested in buying ipamorelin online should therefore exercise great caution when selecting a vendor.

Our team at Peptides.org has interacted and ordered from every major brand in the industry, and are pleased to recommend the following source of research-grade ipamorelin:

Limitless Life

At Peptides.org, we highly recommend Limitless Life for high-quality research peptides. Their commitment to quality and purity is unmatched, and they offer flexible shipping and returns. In addition, they’ve been recognized for their business practices and are highly rated by customers. 

Below are a few more reasons we like Limitless Life:

  • Independently Tested Products: By working with three different third-party laboratories, Limitless Life is able to offer research peptides verified to have a purity rating of 99% or greater.
  • Recognized for Business Practices: As the only peptide company accredited by the Better Business Bureau, Limitless Life has earned an excellent reputation for good business practices.
  • Reliable Shipping: Limitless Life processes many orders and ships them out on the same day. They also aim to have all orders completely processed and shipped out within 48 hours of placing the order.
  • Simple Returns: Limitless Life’s hassle-free return policy and affordable shipping insurance highlight their commitment to support and service service.

In addition to ipamorelin, this vendor also offers an ipamorelin + CJC-1295 No DAC blend which gets rave reviews from the research community.

Buy Ipamorelin from the top-rated research peptides vendor...


Bacteriostatic Water and Ipamorelin

Every researcher needs the right set of tools to experiment safely and effectively. Particularly when working with Ipamorelin, as well as other therapeutic peptides, handlers must be properly equipped.

Standard protocols for peptide administration and storage call for sterile essentials such as vials, bacteriostatic water and alcohol wipes.

Gathering the full set of materials can be an arduous task. Fortunately, the Peptides.org team is here to help with our number one recommended provider of research supplies.


Side Effects of Ipamorelin | Verdict

Having reviewed the available research, it is clear that ipamorelin is an under-researched growth hormone (GH) secretagogue that has strong clinical and therapeutic potential. It appears to be a potent stimulator of both GH and IGF-1 to an extent comparable with exogenous GH therapy, and it has a significant impact on body composition.

Ipamorelin has yet to pass phase two clinical trials, and further human studies evaluating are required before drawing any conclusions about this peptide’s side effects and long-term safety.

Ipamorelin certainly presents an interesting opportunity for further longitudinal studies and would be a strong candidate for medical research in metabolic syndrome and hypogonadism.

To source Ipamorelin for research, we recommend visiting our top-rated vendor.


References

  1. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005 Apr;85(2):495-522. doi: 10.1152/physrev.00012.2004. PMID: 15788704.
  2. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001 Dec;86(12):5992. doi: 10.1210/jcem.86.12.8111. PMID: 11739476.
  3. Raun, K, Hansen, B., Johansen, N., Thogersen, H, Madsen, K, Ankersen, M, & Andersen, P. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 139 (5): 552–561.
  4. Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. J Exp Pharmacol. 2012 Oct 19;4:149-55. doi: 10.2147/JEP.S35396. PMID: 27186127; PMCID: PMC4863553.
  5. Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014 Dec;29(12):1527-34. doi: 10.1007/s00384-014-2030-8. Epub 2014 Oct 21. PMID: 25331030.
  6. Sinha, Deepankar K et al. “Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.” Translational andrology and urology vol. 9,Suppl 2 (2020): S149-S159. doi:10.21037/tau.2019.11.30
  7. Delaney CP, Marcello PW, Sonoda T, Wise P, Bauer J, Techner L. Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study. Surg Endosc. 2010 Mar;24(3):653-61. doi: 10.1007/s00464-009-0652-7. Epub 2009 Aug 18. PMID: 19688390.
  8. Estrada, R. Cañete; Jiménez-Reina, L.; de la Torre, M.J.; Bernal, J. (2002). “Chronic In Vivo Ipamorelin Treatment Stimulates Body Weight Gain and Growth Hormone (GH) Release In Vitro in Young Female Rats. European Journal of Anatomy. 6(1): 37–46.
  9. Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489.
  10. Meinhardt U, Nelson AE, Hansen JL, Birzniece V, Clifford D, Leung KC, Graham K, Ho KK. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med. 2010 May 4;152(9):568-77. doi: 10.7326/0003-4819-152-9-201005040-00007. PMID: 20439575.
  11. George R. Merriam, Suzanne Barsness, David Buchner, Monica Kletke, Lawrence H. Larsen, Karen E. Moe, Robert S. Schwartz, and Michael V. Vitiello.Journal of Anti-Aging Medicine.Dec 2001.331-343.http://doi.org/10.1089/10945450152850650
  12. Bartke A. Growth Hormone and Aging: Updated Review. World J Mens Health. 2019 Jan;37(1):19-30. doi: 10.5534/wjmh.180018. Epub 2018 May 11. PMID: 29756419; PMCID: PMC6305861.

Scientifically Fact Checked by:

David Warmflash, M.D.

Table of Contents
    Add a header to begin generating the table of contents